As a result, targets of AMGB were found to be associated with the TNF signaling pathway, insulin signaling pathway, and peroxisome proliferator-activated receptors (PPAR) signaling pathway which contributes to the development of NAFLD [24] (Figure 3C). Here, TNF is linked to metabolic dysfunction-associated steatotic liver disease.